Rosario Campos-Mojena

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
More potent antitumor activity is desired in Interferon (IFN)-treated cancer patients. This could be achieved by combining IFN alpha and IFN gamma. The aim of this work was to characterize the(More)
  • 1